Baseline’s AI platform helps pharmaceutical companies eliminate months of manual work during clinical trials by automating the study build, data transformation, and analysis creation. This can save a single trial up to $18M in direct costs and lost revenue.
The main document in a clinical trial is the study protocol. At large companies, floors of people use the protocol to create the study data collection forms, clinical database design, error checks, analysis code, and data transformation mappings. This makes the process both expensive and time-consuming, with a single day lost in a clinical trial costing 50k-300k (depending on phase).
We offer a three-part solution:
Implementing our AI workflows can save a single phase 3 clinical trial up to $18M in direct costs and lost revenue.
📘 Backstory
We’re Nabil and Zoe — two recent MIT grads who want to help bring new treatments to patients in need faster. We noticed that despite drug discovery being faster than ever, new treatments for things our friends and family needed seemed to rarely make it to market. Zoe also participated in a clinical trial herself and wanted to see the system improve.
If you or anyone you know are in pharma/biotech or running clinical trials, we’d love to chat! Please reach out to us at founders@baselinetrials.com.